LLGL2 and breast carcinoma: LLGL2 expression is reduced in colorectal and breast cancers, and overexpression of zinc finger E box-binding homologous protein 1 (ZEB1) inhibits LLGL2 expression, leading to the loss of epithelial cell polarity and increased metastasis [16].